Life Scientist > Lab Technology

Looking ahead

22 June, 2005 by Graeme O'Neill

Peter Beattie talks to Graeme O'Neill about his vision of the future for Queensland bioscience.


States of the nation

22 June, 2005 by Cristy Burne

State government policy has been vital in helping to shape the Australian biotechnology industry. Here, Cristy Burne takes us for a tour of Western Australia, the state that later this year will host the national biotech conference.


Australian biotechs partner far and wide

22 June, 2005 by Michael Vitale

There's no tyranny in distance for some globetrotting Australian biotechnology companies, writes Michael Vitale


Bio21: The co-op for science commerce

22 June, 2005 by Anne Fletcher

Opened by the Victorian premier earlier this month, the Bio21 Institute provides a structure in which research, business incubation and commercialisation are all conducted under one collaborative roof, Anne Fletcher reports.


Transforming technology

22 June, 2005 by Susan Williamson

The nanotech sector in Australia is growing with potential.


In Brief: SciGen, Institute of Drug Technology, Phosphagenics

21 June, 2005 by Ruth Beran

SciGen (ASX:SIE) has executed a commercialisation agreement with Rangs Pharmaceuticals for the commercialisation of insulin in Bangladesh.


Baker Institute spin-off enters agreement

20 June, 2005 by Susan Williamson

V-Kardia, the first spin-off company from the Baker Heart Research Institute in Melbourne, has entered into an agreement with Californian-based molecular cardiology company, Celladon, to develop and supply its V-Focus device for percutaneous delivery of gene therapy for congestive heart failure.


Taskforce to advise government on investment in medical research

20 June, 2005 by Susan Williamson

The federal government has set up the Private Sector Investment Taskforce to come up with strategies to gain more support for Australian researchers from business and philanthropic funds, both in Australia and overseas.


Believe the hype

20 June, 2005 by Graeme O'Neill

Is RNAi the real deal? Graeme O'Neill asked Australian scientist and global authority John Mattick.


Dreams, reality and commercialisation

20 June, 2005 by Keith Williams

Keith Williams reflects on the long and winding road he has travelled as a player in the filed of protein science.


Committee for Melbourne report calls for action

16 June, 2005 by Ruth Beran

Victoria won't meet its objective of becoming a top five global biotech location by 2010 if Victorian biotech companies fail to attract expansion capital, according to a report released today by the Committee for Melbourne (CfM).


Funding for ARC centres of excellence and federation fellowships

15 June, 2005 by Susan Williamson

Eleven new ARC centres of excellence and 24 federation fellowship receipients will share $162 million in federal government funding.


Victorian Premier presents Award for Medical Research

14 June, 2005 by Ruth Beran

Two Melbourne researchers, Dr Merlin Thomas and Dr Stephen Ting, have jointly won the 2005 Victorian Premier's Award for Medical Research.


Two PhD students win inaugural Qiagen prize

09 June, 2005 by Ruth Beran

Two PhD students at the University of Melbourne's Department of Microbiology and Immunology were today awarded cash prizes towards travel to an international conference by life science company Qiagen.


ASMR president rallies for medical research funding

09 June, 2005 by Susan Williamson

The president of the Australian Society for Medical Research has made a call for action from researchers to campaign for more federal government funding for medical research.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd